Search
All
ANI provides an objective, noninvasive, and continuous way to automatically monitor the pain level of patients. The Root platform, with its open architecture and built-in...
New collaboration to evaluate the potential of bacterial antigens that mimic tumor antigens and neoantigens ("onco-mimics") to drive immune responses.
Funds will be used to advance Axial’s gut-targeted programs in Parkinson’s Disease and Autism Spectrum Disorder. Seventure Partners commits new funding from...
Phage therapy company BiomX Ltd. (Ness Ziona, Israel) raised a $32 million series B round on Wednesday, 20th February, that will take its lead candidate, acne therapy BX001,...
Vedanta Bioscience, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human...
The latest investment will help drive expansion and accelerate research & development to introduce new and novel ingredients to the market.
The $30 million in new investment will fuel expansion and accelerate R&D project execution. This funding round opens up an opportunity to explore different ways to meet...
A-Mansia Biotech, a microbiome company, has announced the appointment of Cees de Jong as the Chairman of its Board of Directors. His experience of successfully managing several...
It's a decisive step in BALYO’s development that supports the added value of BALYO’s robotic solutions and will potentially boost their deployment. AMAZON would obtain the...
Talentsoft, the European leader in learning and human capital management software, today announced that it has closed a funding round of $50 million. Francisco Partners leads...
